Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Nov 19, 2026
TickeronGET DAILY SIGNALS
Understanding YMAR: FT Vest's Approach to Buffered International Equity Exposure

Understanding YMAR: FT Vest's Approach to Buffered International Equity Exposure

Key Takeaways

  • YMAR is an actively managed exchange-traded fund (ETF) from FT Vest, a First Trust and Vest Financial partnership, launched in March 2021.
  • The fund seeks to match the price return of the EFA iShares MSCI EAFE ETF, up to a preset upside cap, while buffering the first 15% of losses over each one-year outcome period.
  • It is a "defined outcome" or "buffer" ETF that uses customized FLEX Options rather than directly owning international stocks.
  • YMAR carries a net expense ratio of 0.90% and is non-diversified, concentrating its portfolio holdings in a small number of options contracts.
  • The fund is designed for investors seeking developed international equity exposure with built-in, limited downside protection and capped upside.

Fund Background and Core Objective

FT Vest International Equity Moderate Buffer ETF – March, trading under the ticker YMAR, stands out as a specialized ETF in the defined outcome space. Rather than holding a portfolio of overseas stocks directly, this fund relies on an options-based structure to deliver exposure to developed international markets. It aims to track the price return of the iShares MSCI EAFE ETF (EFA) up to a set cap, while shielding investors from the first 15% of losses over each annual outcome period that resets in March. This setup appeals to those who want international diversification with some built-in risk management.

Investment Strategy and How It Works

YMAR is actively managed and does not follow an index. Its goal is to deliver returns, before fees and expenses, that align with EFA performance within a defined band. The strategy employs FLEX Options tied to EFA, including purchased and written calls and puts that together create the buffer and cap. I also checked this using Tickeron’s AI Screener to compare the approach against other international equity options. The fund trades on the Cboe BZX exchange, was launched on March 19, 2021, and carries a 0.90% net expense ratio. Portfolio holdings tend to be highly concentrated, often limited to a handful of options positions plus cash equivalents. Outcomes are intended for full-period holders, and both the cap and remaining buffer reset annually.

Market Exposure and Positioning

Although implemented through options, the fund’s returns ultimately reflect the MSCI EAFE index, which covers developed markets outside the U.S. and Canada. This includes broad sector weights historically tilted toward financials and industrials, alongside technology, healthcare, and consumer areas. Geographically, it spans the eurozone, Japan, the United Kingdom, and similar economies. Within the defined outcome category, FT Vest has established a range of buffer strategies, and YMAR brings that framework specifically to international equities, offering a structured alternative to conventional overseas stock funds.

Investor Considerations and Trade-Offs

One thing that stands out is how YMAR functions as a risk-management tool for those seeking international exposure without full volatility. The 15% buffer can help smooth returns during moderate declines, making it suitable as a satellite holding alongside traditional allocations. From what I see, the design works best in range-bound or modestly performing markets, where the protection adds value, though the cap limits participation in strong rallies. I’m watching this closely because timing matters—results are path-dependent, and mid-period purchases or sales can lead to different outcomes than the stated buffer and cap.

Key Risks to Evaluate

Investors should consider the upside cap, which prevents gains above the preset level if EFA rises sharply. The buffer covers only the first 15% of losses, after which declines occur one-to-one. Fees reduce the effective buffer and cap, and the fund’s non-diversified, options-concentrated structure introduces additional risks around counterparty exposure and tracking differences versus plain international equity funds. Currency fluctuations and market volatility in overseas markets remain relevant factors as well.

Using Tickeron AI Tools in Research

When evaluating options-based ETFs like YMAR, I find it helpful to run additional screens for context. Tickeron’s AI Screener allows me to filter across thousands of ETFs and stocks using technical indicators, fundamentals, volatility measures, and AI signals. This supports a more efficient process for identifying ideas that align with a defined-outcome strategy without replacing core due diligence.

Conclusion

Overall, YMAR provides a rules-based way to access developed international markets with a preset buffer and cap. While it is not a replacement for standard international equity exposure and involves clear trade-offs, the structure offers transparency for investors who prioritize downside cushioning within a one-year horizon.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: YMAR

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


YMAR in upward trend: price expected to rise as it breaks its lower Bollinger Band on November 17, 2026

YMAR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 34 of 41 cases where YMAR's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +0.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where YMAR advanced for three days, in 250 of 336 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on YMAR as a result. In 51 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.

The Moving Average Convergence Divergence Histogram (MACD) for YMAR turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 27 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 59%.

YMAR moved below its 50-day moving average on November 16, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where YMAR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.

The Aroon Indicator for YMAR entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Industry description

The investment seeks to provide investors with returns that match the price return of the iShares MSCI EAFE ETF (the "underlying ETF"). Under normal market conditions, the fund will invest substantially all of its assets in FLexible EXchange® Options ("FLEX Options") that reference the price performance of the iShares MSCI EAFE ETF (the "underlying ETF"). FLEX Options are customized equity or index option contracts that trade on an exchange, but provide investors with the ability to customize key contract terms like exercise prices, styles and expiration dates. It is non-diversified.
AI Screener 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
SAP's U.S. shares fell from Monday's close of $233.83 to $221.99 by late Tuesday morning in New York, a -5.06% decline recorded during regular trading hours. The company-specific trigger was the announced exit of Chief Customer Officer Thomas Saueressig, an executive board member since 2019, who will leave at the end of March 2027 to become CEO of IONOS; the disclosure came before the U.S. open.
IonQ slid from Monday's close of $26.45 to $24.73 on Tuesday, a -6.50% move that unfolded during regular trading hours after modest premarket gains faded. The decline was sector-driven rather than company-specific: quantum and AI-adjacent speculative names extended a multi-session liquidation ahead of Nvidia's quarterly report, with unease over Nvidia's abrupt CEO transition keeping risk appetite weak.
Cerebras Systems (CBRS) dropped -6.48% to $97.43 in regular trading from the prior close of $104.18, reversing an early premarket gain of roughly +3%. No verified news or fundamental catalyst found for the intraday reversal; the move is likely profit-taking after the stock's +21% post-earnings rebound, consistent with a name that averages a ±4.5% daily swing and remains 65% below its first-day close.
CBRS fell -6.07% to $97.86 in the opening minutes of Wednesday's regular session, down from Tuesday's close of $104.18 — the move occurred during market hours, not premarket or after-hours. No verified news or fundamental catalyst found: no new filing, contract, or analyst action explains the drop, which is likely continued give-back from the post-earnings pop and the stock's habitual volatility — CBRS has averaged a ±4.5% daily swing over the past 60 sessions, and 17 of those sessions moved as much or more.
Understanding YMAR: FT Vest's Approach to Buffered International Equity Exposure